قالب وردپرس درنا توس
Home / Health / FDA commissioner refuses to contradict Trump on hydroxylchlorinin – Raw Story

FDA commissioner refuses to contradict Trump on hydroxylchlorinin – Raw Story



President Donald Trump’s head in the Food and Drug Administration has refused to say hydroxychloroquine should not be used to treat coronavirus.

The FDA revoked the emergency use authorization for hydroxychloroquine on June 15 and issued a new warning about potential side effects from the drug on July 1, but commissioner Dr. Stephen Hahn told NBC “Today” may still be prescribed to treat COVID-19.

“I want to ask you about hydroxychloroquine,” said host Savannah Guthrie. “It’s in the news again. The president re-released a video promoting it, he even said, ‘I took it for a period of 14 days, and I’m here.’ I don’t think you lose anything by doing this. The vice president said yesterday, “Many Americans have had positive experiences with hydrochloroquine.”

; The FDA revoked the emergency authorization for the medicine because it was ineffective and unsafe, but it was potentially dangerous. “

“Once and for all, should people take hydroxychloroquine?” she added.

Hahn refused to contradict president and Vice President Mike Pence.

“Just to be clear, we revoked the EUA, an authorization for emergency use, at the request of another government agency, BARDA (Biomedical Advance Research and Development Authority),” Hahn said. “This was authorized for sick, hospitalized patients. We had data that when this medicine was combined with others, there were some risks associated with that. But the question you ask me is a decision between a doctor and a patient. Doctor and patient they need to evaluate the data out there. The FDA does not regulate the practice of medicine. That, in the privacy of a doctor / patient relationship, is where that decision should be made. “

Guthrie asked the FDA commissioner, who would be in charge of approving any potential vaccine, if he was concerned about misinformation about hydroxylchlorinin.

“What I am concerned about is that the FDA provides all the information on side effects, potential side effects, as well as efficacy,” Hahn said. As you know, these drugs have been approved for a number of years for other indications by the FDA. We know they are safe in those settings. We want to make sure that the right information is provided to providers, so that they can make this decision with patients. “

Report fonts and corrections for: [email protected].




Source link